There is described a process for the production of a compound of formula I, ##STR1## in which R is hydrogen or alkyl Cl to 6, and R.sub.5 and R.sub.10, which may be the same or different, are each hydrogen or alkyl Cl to 6, or a pharmaceutically acceptable derivative thereof, which comprises removal of an activating group from a compound of formula II, ##STR2## or a suitable derivative thereof, in which R, R.sub.5 and R.sub.10 are as defined above, and X represents an activating group, and if desired or necessary converting the resulting compound of formula I to a pharmaceutically acceptable derivative thereof, or vice versa. There is also described a process for the production of a compound of formula II in which R is hydrogen, or a suitable derivative thereof, which comprises reaction of a compound of formula III, ##STR3## or a suitable derivative thereof, in which R.sub.5 and R.sub.10 are as defined above, with a compound of formula IV, X--N.dbd.C.dbd.O IV in which X is as defined above.
描述了一种生产化合物I的方法,其中R是氢或烷基Cl至6,而R.sub.5和R.sub.10,可以相同也可以不同,分别是氢或烷基Cl至6,或其药学上可接受的衍
生物,该方法包括从化合物II中去除一个活化基团,其中R、R.sub.5和R.sub.10如上所定义,X代表一个活化基团,如有需要,将得到的化合物I转化为其药学上可接受的衍
生物,或反之亦然。还描述了一种生产化合物II的方法,其中R是氢,或其适当的衍
生物,该方法包括使化合物III与化合物IV反应。